| 摘要 |
In various aspects, the present invention relates to novel compounds, which modulate calcitonin and amylin receptor activity; to processes for the preparation of such compounds; and to pharmaceutical compositions including such compounds. Compounds of the invention are useful as calcitonin and/or amylin agonists and in the treatment of bone disease such as osteoporosis, Paget's disease, hypercalcemia, and in the treatment of metabolic diseases, such as insulin-requiring states. |
| 申请人 |
KEMIA, INC.;PRYOR, KENT;SAIAH, EDDINE;KAHL, JEFFREY, D.;DELAET, NANCY, G., J.;ROBERTS, EDWARD;URBAN, JAN;SEBO, LUBOMIR;LUM, CHRISTOPHER;NAKANISHI, HIROSHI |
发明人 |
PRYOR, KENT;SAIAH, EDDINE;KAHL, JEFFREY, D.;DELAET, NANCY, G., J.;ROBERTS, EDWARD;URBAN, JAN;SEBO, LUBOMIR;LUM, CHRISTOPHER;NAKANISHI, HIROSHI |
